Yan Liang
Papers
1
Total Citations
50
H-Index
1
About
Dr. Yan Liang has made transformative contributions to breast cancer surgery, particularly in evaluating the long-term oncologic safety of minimally invasive approaches. Her landmark 2022 study, "Association of Long-term Oncologic Prognosis With Minimal Access Breast Surgery vs Conventional Breast Surgery," with 50 citations, directly addressed a critical gap in the literature by comparing long-term outcomes between minimal access breast surgery (MABS) and conventional breast surgery (CBS). This work provided essential evidence that MABS offers comparable long-term oncologic prognosis to CBS, helping to validate less invasive techniques for breast cancer management. Dr. Liang’s research bridges surgical innovation with rigorous outcome assessment, influencing clinical guidelines and patient counseling. Her findings have empowered surgeons to offer MABS with greater confidence, improving cosmetic results and recovery without compromising survival. By systematically analyzing survival data, recurrence rates, and quality-of-life metrics, she has advanced patient-centered care in surgical oncology. Dr. Liang’s scholarship continues to shape the evolution of breast cancer treatment, making her a leading voice in the integration of minimally invasive techniques into standard practice.
Research Focus
Key Achievements
Top Papers
- 1